These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35013077)

  • 1. Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insights.
    Lindblom J; Mohan C; Parodis I
    Curr Opin Rheumatol; 2022 Mar; 34(2):139-149. PubMed ID: 35013077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
    Front Immunol; 2022; 13():885307. PubMed ID: 35720325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis.
    Soliman SA; Stanley S; Vanarsa K; Ismail F; Mok CC; Mohan C
    Front Immunol; 2022; 13():910993. PubMed ID: 36091001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.
    Amer AS; Abdel Moneam SM; Hashaad NI; Yousef EM; Abd El-Hassib DM
    Clin Rheumatol; 2024 Mar; 43(3):1015-1021. PubMed ID: 38294724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
    Gómez-Puerta JA; Ortiz-Reyes B; Urrego T; Vanegas-García AL; Muñoz CH; González LA; Cervera R; Vásquez G
    Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
    Smith EM; Jorgensen AL; Midgley A; Oni L; Goilav B; Putterman C; Wahezi D; Rubinstein T; Ekdawy D; Corkhill R; Jones CA; Marks SD; Newland P; Pilkington C; Tullus K; Beresford MW
    Pediatr Nephrol; 2017 Feb; 32(2):283-295. PubMed ID: 27590021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
    Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
    Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review.
    Radin M; Miraglia P; Barinotti A; Fenoglio R; Roccatello D; Sciascia S
    Am J Nephrol; 2021; 52(7):559-571. PubMed ID: 34515043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response.
    Kim JW; Baek WY; Jung JY; Kim HA; Lee SW; Suh CH
    Front Immunol; 2024; 15():1369385. PubMed ID: 38915417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus.
    Parodis I; Gokaraju S; Zickert A; Vanarsa K; Zhang T; Habazi D; Botto J; Serdoura Alves C; Giannopoulos P; Larsson A; Svenungsson E; Gunnarsson I; Mohan C
    Rheumatology (Oxford); 2020 Sep; 59(9):2237-2249. PubMed ID: 31722419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature.
    Palazzo L; Lindblom J; Mohan C; Parodis I
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis.
    Satirapoj B; Kitiyakara C; Leelahavanichkul A; Avihingsanon Y; Supasyndh O
    BMC Nephrol; 2017 Aug; 18(1):263. PubMed ID: 28778196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary neutrophil gelatinase-associated lipocalin as a marker for disease activity in lupus nephritis.
    El Shahawy MS; Hemida MH; Abdel-Hafez HA; El-Baz TZ; Lotfy AM; Emran TM
    Scand J Clin Lab Invest; 2018 Jul; 78(4):264-268. PubMed ID: 29533691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
    Mirioglu S; Cinar S; Yazici H; Ozluk Y; Kilicaslan I; Gul A; Ocal L; Inanc M; Artim-Esen B
    Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings.
    Abd-Elkareem MI; Al Tamimy HM; Khamis OA; Abdellatif SS; Hussein MR
    Clin Exp Nephrol; 2010 Dec; 14(6):548-57. PubMed ID: 20714774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Lupus Nephritis.
    Alforaih N; Whittall-Garcia L; Touma Z
    J Appl Lab Med; 2022 Oct; 7(6):1450-1467. PubMed ID: 35932197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment.
    Davies JC; Carlsson E; Midgley A; Smith EMD; Bruce IN; Beresford MW; Hedrich CM;
    Rheumatology (Oxford); 2021 Aug; 60(8):3747-3759. PubMed ID: 33313921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis.
    Li Y; Tang C; Vanarsa K; Thai N; Castillo J; Lea GAB; Lee KH; Kim S; Pedroza C; Wu T; Saxena R; Mok CC; Mohan C
    J Autoimmun; 2024 Feb; 143():103165. PubMed ID: 38194790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.